Dry eye disease and glaucoma often occur together, especially because some glaucoma eye drops can affect the tear film and make symptoms like burning, irritation, watering, or fluctuating vision worse. Early diagnosis and treatment of both conditions can improve comfort and help protect long-term vision.
Glaucoma and dry eye disease occur together more often than chance alone explains. If your eyes burn, sting, or feel gritty while you are on glaucoma drops, you are not imagining it. This combination is common, clinically important, and often undertreated.
Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care. She is rated 5 stars across 1,500+ patient reviews on Google.
How Common Is Glaucoma and Dry Eye Overlap?
Studies consistently show that 40 to 60 percent of glaucoma patients meet diagnostic criteria for dry eye disease. The reverse is also true: people with moderate to severe dry eye carry a higher risk of developing glaucoma-related damage. These are not coincidental companions. They share biological mechanisms, and each condition can quietly worsen the other.
Why Does Dry Eye Develop in Glaucoma Patients?
The preservative problem
Most glaucoma eye drops contain benzalkonium chloride (BAK) as a preservative. BAK is effective at keeping the bottle sterile, but it is toxic to the cells of the ocular surface. It disrupts the tear film, damages goblet cells (the cells that produce the mucin layer of your tears), and triggers chronic inflammation.
Patients who use two or three glaucoma drops daily — each containing BAK — are exposing their eyes to this preservative four, six, or more times every day. Over months and years, the cumulative damage is significant. The conjunctiva becomes inflamed, the cornea loses its smooth optical surface, and the eyes feel perpetually uncomfortable.
This is not a rare side effect. It is an expected biological consequence of long-term BAK exposure, and it is one of the most underrecognised sources of glaucoma-related suffering.
Pre-existing risk
Dry eye disease is more common in the same demographic groups that develop glaucoma: older adults, women after menopause, and people with autoimmune conditions. Many patients arrive at a glaucoma diagnosis already carrying a degree of ocular surface disease. Adding BAK-containing drops to a compromised surface accelerates the damage.
Reduced blink rate
Glaucoma patients and patients with dry eye often share a common modern risk factor: prolonged screen use. Reduced blink rate during screen time is one of the fastest-growing contributors to evaporative dry eye, and it worsens the tolerance to topical medications.
Why Does This Overlap Matter Clinically?
Medication adherence
Dry eye makes glaucoma drops uncomfortable. Burning, stinging, and a sense of grittiness after instillation are among the most common reasons patients quietly reduce their drop frequency or stop altogether. This is rational behaviour in response to pain — but the result is uncontrolled intraocular pressure and silent glaucoma progression.
Treating dry eye is not a cosmetic afterthought. It is a strategy for protecting adherence, which protects the optic nerve.
Diagnostic accuracy
Dry eye causes variable intraocular pressure readings. Epithelial irregularity from a damaged ocular surface can affect tonometry (pressure measurement) and cause artificially high or variable readings. This creates noise in the data your glaucoma specialist depends on.
Similarly, a poor ocular surface causes artefacts in OCT scans and visual field tests. Blurring from unstable tear film produces dips and losses in visual field testing that mimic glaucoma progression. Distinguishing true nerve damage from tear-film artefact requires a clinician who is looking for both.
Quality of life
Glaucoma itself does not hurt and often produces no symptoms until late. But the treatment — the drops — can make patients miserable. Chronic ocular surface pain, light sensitivity, and fluctuating vision are quality-of-life burdens that patients often accept as inevitable. They are not inevitable.
How Do We Assess This in the Clinic?
A comprehensive evaluation for a glaucoma patient with ocular surface complaints includes:
- Tear film assessment: Tear breakup time (TBUT) measures how quickly your tear film breaks apart after a blink. In dry eye, this is shortened.
- Ocular surface staining: Fluorescein and lissamine green dyes reveal damaged cells on the cornea and conjunctiva.
- Meibomian gland evaluation: Most dry eye in glaucoma patients is evaporative, caused by dysfunction of the oil-producing meibomian glands at the lid margins.
- Symptom questionnaires: Validated tools like OSDI (Ocular Surface Disease Index) capture the patient experience beyond what the slit lamp shows.
- Review of the current drop regimen: How many drops, which preservatives, how many times daily.
What Are the Management Options?
Switching to preservative-free formulations
This is often the single most impactful intervention. Preservative-free glaucoma drops deliver the same intraocular pressure-lowering effect without the chronic ocular surface toxicity. Multiple classes of glaucoma medication are now available in preservative-free formats: prostaglandin analogues, beta-blockers, carbonic anhydrase inhibitors, and fixed-dose combinations.
The transition requires some planning — not all formulations are available in preservative-free versions in every market, and cost is a factor — but for patients with documented ocular surface disease, this is a clinically justified switch that most guidelines now support.
Fixed-dose combination drops
Instead of using two bottles separately (each with its own preservative load), a fixed-dose combination delivers two active ingredients in one drop. This halves the number of preservative exposures per day. For patients who genuinely need two active agents, this is a practical step even before moving to preservative-free options.
Treating the dry eye directly
Ocular surface disease responds to targeted treatment. The approach depends on the type and severity:
- Artificial tears: Lubricating drops, preferably preservative-free, used consistently throughout the day. These dilute residual BAK, stabilise the tear film, and reduce surface friction.
- Warm compresses and lid hygiene: For meibomian gland dysfunction, daily warm compress application followed by gentle lid massage improves the quality of the oily tear layer.
- Omega-3 supplementation: Good evidence supports dietary omega-3 fatty acids for meibomian gland function and tear quality.
- Anti-inflammatory therapy: Topical cyclosporine (Restasis, Ikervis) or lifitegrast addresses the inflammatory cycle that perpetuates chronic dry eye. In patients with significant ocular surface inflammation, this can be transformative.
- Punctal plugs: Small silicone plugs inserted into the tear drainage points slow the drainage of natural tears, keeping the eye surface better hydrated.
Laser and surgical IOP control
For some patients, reducing or eliminating the need for topical drops altogether is the right goal. Selective laser trabeculoplasty (SLT) can lower IOP without any drops. For more advanced glaucoma, surgical options including minimally invasive glaucoma surgery (MIGS) and trabeculectomy may reduce drop burden significantly. When a patient’s ocular surface is severely compromised by long-term drop use, a surgical discussion is worth having.
A Note on Sequence and Timing
When a patient presents with both conditions, the sequence of assessment matters. Dry eye can artificially distort IOP readings and OCT quality. I prefer to stabilise the ocular surface first — or at least treat both simultaneously — so that subsequent glaucoma monitoring data is reliable. A visual field test performed through an unstable tear film is not a trustworthy test.
What Should You Tell Your Doctor?
If you are being treated for glaucoma and your eyes feel uncomfortable, please say so explicitly. Many patients assume irritation is part of the package and do not raise it. Your doctor needs to know:
- Which symptoms bother you most (burning, grittiness, blurred vision, light sensitivity)
- Whether symptoms are worse at certain times of day or after drop instillation
- Whether you have ever reduced or skipped your drops because of discomfort
- Whether you use a screen for extended hours daily
This information changes the clinical approach. It does not make you a difficult patient — it makes your care more precise.
Frequently Asked Questions
Can glaucoma drops cause dry eye?
Yes. Most glaucoma drops contain benzalkonium chloride, a preservative that damages the ocular surface over time. Long-term exposure causes inflammation, goblet cell loss, and dry eye disease. Switching to preservative-free formulations often brings significant relief.
Do I have to choose between treating my glaucoma and treating my dry eye?
No. Both conditions can and should be managed simultaneously. In many cases, treating dry eye actively improves the tolerability of glaucoma drops and supports adherence to treatment, which protects the optic nerve.
Are preservative-free glaucoma drops as effective as regular drops?
Yes. The active ingredient is the same. The preservative is only there to keep the bottle sterile between uses. Preservative-free formulations use single-dose units instead, delivering the same intraocular pressure-lowering effect without the surface toxicity.
Can dry eye affect my glaucoma test results?
Yes. An unstable tear film causes variable IOP readings and artefacts in visual field and OCT testing. This is one reason a thorough ocular surface assessment is part of comprehensive glaucoma care.
I use three different glaucoma drops. Is that a problem for my eyes?
Three separate bottles often means three doses of BAK per application. This is a significant preservative load. A conversation about fixed-dose combinations or preservative-free alternatives is worth having with your glaucoma specialist.
Is laser treatment an option if my eyes cannot tolerate drops?
Yes. Selective laser trabeculoplasty (SLT) can lower IOP and reduce dependence on drops. For patients whose ocular surface disease is severe and driven by drop toxicity, reducing the drop burden through laser or surgery is a clinically sound strategy.
Internal Linking Architecture Statement
This page is part of the Glaucoma Hub hub. Read about our full approach to glaucoma diagnosis, monitoring, and treatment. Please also read our Dry Eye Hub. Here’s another heartening patient story: Tired of glaucoma eyedrops.
About the Author
This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.
She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.
As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.
1500+ Five Star Patient Reviews Google Business Profile
If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation
Read her research on PubMed | Google Scholar | ResearchGate | ORCID
Upload your reports for a structured review.| www.drshibalbhartiya.com | +91 88826 38735
Leave a review on Google
Read More
Basics of Dry Eye, Dry Eye Second Opinion, Dry Eye: A Chronic Disease
Why Do Women Get Dry Eye More Often? Menopause and Dry Eye
Dry Eyes: Natural Remedies, Dry Eyes: Tips to Soothe Sore Eyes
Why Dry Eye Is Worse in Air Conditioning and on Flights
Screen Fatigue, Why Vision Becomes Blurred After Reading or Screen Use,
Why Your Eyes Water Constantly, Omega-3 and Dry Eye, Why Are Your Dry Eye Drops Not Working
Glaucoma Eye Drops: The Complete Guide, Laser or Eye Drops for Glaucoma
Managing Glaucoma Eye Drop Side Effects, Which Is the Best Eyedrop for Glaucoma?